Bury, United Kingdom

Robert H Hargreaves

This inventor holds 1 USPTO granted patent. Top assignees: Cancer Research Campaign Tech (London), The University of Salford, University Technology Corporation. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert H Hargreaves. Retrieved from https://idiyas.com/inventor/robert-h-hargreaves

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert H Hargreaves

Introduction

Robert H Hargreaves is a notable inventor based in Bury, GB. He has made significant contributions to the field of anti-tumor agents, particularly through his innovative patent related to DT-diaphorase. His work has implications for cancer treatment, showcasing the importance of research in medical advancements.

Latest Patents

Hargreaves holds a patent for a novel benzoquinone, specifically 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone and its esters. This invention is designed to treat tumors that exhibit elevated levels of the enzyme DT-diaphorase. The potential applications of this compound could lead to improved therapeutic options for cancer patients.

Career Highlights

Throughout his career, Hargreaves has worked with prominent organizations such as Cancer Research Campaign Technology in London and University Technology Corporation. His experience in these institutions has allowed him to contribute to significant advancements in cancer research and treatment.

Collaborations

Hargreaves has collaborated with notable individuals in his field, including John Butler and David B Ross. These partnerships have likely enhanced the impact of his research and innovations.

Conclusion

Robert H Hargreaves is a distinguished inventor whose work in anti-tumor agents exemplifies the critical role of innovation in medicine. His contributions continue to influence cancer treatment strategies and highlight the importance of ongoing research in this vital area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…